Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-01 Conversion | 2024-11-05 6:02 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Capital GP IX LLC Director | 694,444 | $3.6 | 2,677,256 (Indirect) | View | |
| 2024-11-01 Conversion | 2024-11-05 6:02 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Capital GP IX LLC Director | 1,233,506 | $0 | 2,677,256 (Indirect) | View | |
| 2024-11-01 Option Award | 2024-11-05 6:02 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Capital GP IX LLC Director | 1,443,750 | $4 | 2,677,256 (Indirect) | View | |
| 2024-11-01 Conversion | 2024-11-05 6:02 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Capital GP IX LLC Director | 539,062 | $3.2 | 2,677,256 (Indirect) | View |